Title

Renal protein phosphatase 2A activity and spontaneous hypertension in rats

Document Type

Journal Article

Publication Date

1-1-2000

Journal

Hypertension

Volume

36

Issue

6

DOI

10.1161/01.HYP.36.6.1053

Keywords

Dopamine; Hypertension, essential; Hypertension, genetic; Phosphatase; Receptors, dopamine

Abstract

The impaired renal paracrine function of dopamine in spontaneously hypertensive rats (SHR) is caused by hyperphosphorylation and desensitization of the renal D1 dopamine receptor. Protein phosphatase 2A (PP(2A)) is critical in the regulation of G-protein - coupled receptor function. To determine whether PP(2A) expression and activity in the kidney are differentially regulated in genetic hypertension, we examined the effects of a D1-like agonist, fenoldopam, in renal cortical tubules and immortalized renal proximal tubule cells from normotensive Wistar-Kyoto rats (WKY) and SHR. In cortical tubules and immortalized proximal tubule cells, PP(2A) expression and activities were greater in cytosol than in membrane fractions in both WKY and SHR. Although PP(2A) expressions were similar in WKY and SHR, basal PP(2A) activity was greater in immortalized proximal tubule cells of SHR than WKY. In immortalized proximal tubule cells of WKY, fenoldopam increased membrane PP(2A) activity and expression of the regulatory subunit PP(2A)-B56α, effects that were blocked by the D1-like antagonist SCH23390. Fenoldopam had no effect on cytosolic PP(2A) activity but decreased PP(2A)-B56α expression. In contrast, in immortalized proximal tubule cells of SHR, fenoldopam decreased PP(2A) activity in both membranes and cytosol but predominantly in the membrane fraction, without affecting PP(2A)-B56α expression; this effect was blocked by the D1-like antagonist SCH23390. We conclude that renal PP(2A) activity and expression are differentially regulated in WKY and SHR by D1-like receptors. A failure of D1-like agonists to increase PP(2A) activity in proximal tubule membranes may be a cause of the increased phosphorylation of the D1 receptor in the SHR.

Share

COinS